# Evaluating DFPP for Microplastic and PFAS Reduction

> **NCT07658443** · — · ENROLLING_BY_INVITATION · sponsor: **Proxima Health, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Microplastic and Nanoplastic Particle Burden in Peripheral Blood
- Double-Filtration Plasmapheresis

## Interventions

- **PROCEDURE:** Double-Filtration Plasmapheresis With the IN300 Apheresis Device

## Key facts

- **NCT ID:** NCT07658443
- **Lead sponsor:** Proxima Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-06-12
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658443, "Evaluating DFPP for Microplastic and PFAS Reduction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*